Glenmark Pharmaceuticals Ltd (GLENMARK) Shareholding Pattern - Promoter, FII, DII & Public Holdings
As of Jun 2026, promoters held 46.65% of Glenmark Pharmaceuticals Ltd, FIIs 20.89%, DIIs 18.6%, government 0.04% and the public 13.81%, across 2,11,418 shareholders.
| Metric | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 46.65% | 46.65% | 46.65% | 46.64% | 46.64% | 46.65% | 46.65% | 46.65% |
| FIIs | 23.05% | 23.51% | 23.15% | 20.62% | 20.73% | 19.2% | 20.35% | 20.89% |
| DIIs | 13.21% | 13.85% | 14.6% | 17.64% | 18.61% | 20.09% | 19.28% | 18.6% |
| Government | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% |
| Public | 17.06% | 15.96% | 15.56% | 15.05% | 13.97% | 14.02% | 13.7% | 13.81% |
| No. of Shareholders | 1,93,949 | 1,95,059 | 1,92,724 | 1,90,210 | 1,98,789 | 2,01,584 | 1,96,105 | 2,11,418 |